Jump to Navigation
Quantitative
Research
Quantitative Models
Methodology Graphic
EQR White Paper
Investment
Products
Baker's Dozen Model Portfolio
UITs
ETFs
Investor
Tools
Scorecards
Earnings Busters
Sector Detector
Advisors &
Individual Investors
Go to Investors Site
About Us
Our Company
Our People
ADV2A
Contact Us
Search form
Search
You are here:
You are here
Home
»
Feed aggregator
»
Sources
https://seekingalpha.com
URL:
https://seekingalpha.com
Updated:
1 hour 35 min ago
Norsk Hydro: Holding Onto And Adding More To This Winner
Thu, 12/18/2025 - 12:25
Market Voices: Lilly's new obesity pill, NYSE owner eyes crypto firm
Thu, 12/18/2025 - 12:22
Harbor Mid Cap Core ETF Q3 2025 Commentary
Thu, 12/18/2025 - 12:21
2026 S&P 500 Outlook: AI Is Real, But Easy Money Is Gone
Thu, 12/18/2025 - 12:19
OCC removes consent order amendment against Citi
Thu, 12/18/2025 - 12:16
CLOZ: Floating-Rate Income-Hold Case
Thu, 12/18/2025 - 12:08
An Important Warning: Popular Income Stocks Are Getting Risky Here
Thu, 12/18/2025 - 12:05
Lagarde Reiterates The ECB Is In No Rush To Change Rates Anytime Soon
Thu, 12/18/2025 - 12:05
Takeda posts late-stage trial win for oral plaque psoriasis therapy
Thu, 12/18/2025 - 12:03
Trump Media Makes Major Energy Pivot
Thu, 12/18/2025 - 12:01
Helios Technologies: Signs Of Improvement, But Still Only A 'Hold'
Thu, 12/18/2025 - 11:59
Integra Resources Corp. (ITR:CA) Discusses DeLamar Project Feasibility Study Results and Project Evolution - Slideshow
Thu, 12/18/2025 - 11:58
Northeast Community Bancorp: Risks Have Increased, But Valuation Is Still Compelling
Thu, 12/18/2025 - 11:58
Hawkins tops the struggling commodity chemical industry in 2025
Thu, 12/18/2025 - 11:58
Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's
Thu, 12/18/2025 - 11:55
Darden: Still A Quality Hold
Thu, 12/18/2025 - 11:54
Specialty chemicals lag in 2025, but these 10 names have delivered standout gains
Thu, 12/18/2025 - 11:52
Hartford Strategic Income ETF Q3 2025 Commentary
Thu, 12/18/2025 - 11:52
Toast: Buy The Dip As This Company Maneuvers Past Industry Weakness
Thu, 12/18/2025 - 11:49
Kalaris Therapeutics: TH103 Trial Success And $50M Raise Set Stage For Growth
Thu, 12/18/2025 - 11:47
Pages
« first
‹ previous
…
1828
1829
1830
1831
1832
1833
1834
1835
1836
…
next ›
last »